Ex-PRESS glaucoma filtration device (Alcon Laboratories Inc.) for treatment of primary open-angle glaucoma
Record ID 32013000226
English
Authors' recommendations:
Glaucoma refers to a group of eye diseases in which vision is lost due to damage of the optic nerve, which carries visual information from the eye to the brain. Glaucoma is estimated to affect 4 million people in the United States, and it is the second leading cause of blindness. Though it is not preventable, available treatments may slow the progression of glaucoma; therefore early detection is important. Treatments for glaucoma may include eye drops, laser surgery, or incisional surgery. The aim of treatment is to reduce the pressure of the fluid in the eye, known as intraocular pressure (IOP), in an attempt to prevent further damage to the optic nerve. There are several different types
of glaucoma; the most common type is known as primary open-angle glaucoma (POAG). In patients with POAG, fluid may not drain out of the eye properly, despite no physical blockages being evident.
Details
Project Status:
Completed
Year Published:
2012
URL for published report:
The report may be purchased from:http://www.hayesinc.com/hayes/crd/?crd=10657
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
United States
MeSH Terms
- Glaucoma, Open-Angle
Contact
Organisation Name:
HAYES, Inc.
Contact Address:
157 S. Broad Street, Suite 200, Lansdale, PA 19446, USA. Tel: 215 855 0615; Fax: 215 855 5218
Contact Name:
saleinfo@hayesinc.com
Contact Email:
saleinfo@hayesinc.com
Copyright:
2012 Winifred S. Hayes, Inc
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.